¶ Harlequin
¶ Overview
Harlequin is a sativa-dominant high-CBD cultivar that has become one of the most important and widely recommended strains for medical cannabis patients seeking therapeutic relief without the intoxicating effects of high-THC cannabis. With a characteristic CBD:THC ratio of approximately 5:2, Harlequin provides clear-headed, functional relief that allows patients to remain active and productive throughout the day. The strain was created through a complex cross of Colombian Gold, Thai, a Swiss landrace, and a Nepali indica, combining diverse genetics to produce a unique cannabinoid profile. Harlequin's name references its multifaceted genetic heritage -- like the Harlequin character, it draws from multiple sources to create something distinctive.
¶ Quick Stats
| Attribute | Value |
|---|---|
| Type | Sativa-Dominant Hybrid |
| THC % | 4-10% |
| CBD % | 8-16% |
| CBD:THC Ratio | Approximately 5:2 |
| Dominant Terpenes | Caryophyllene, Myrcene, Pinene |
| Flowering Time | 55-65 days |
| Yield | Moderate (350-450 g/m² indoor) |
| Growing Difficulty | Moderate |
¶ Genetics & Lineage
Harlequin's genetic composition draws from four distinct landrace and hybrid sources:
- Colombian Gold -- The legendary Colombian sativa landrace, contributing sativa structure and CBD genetics
- Thai -- Southeast Asian sativa landrace, adding cerebral sativa characteristics
- Swiss landrace -- European landrace genetics, contributing additional CBD expression
- Nepali indica -- Himalayan indica genetics, providing structure and balancing the sativa dominance
Parent lineage: Colombian Gold x Thai x Swiss Landrace x Nepali Indica
The combination of these diverse genetics was specifically selected to produce a high-CBD phenotype. The CBD-rich expression likely originates from the Swiss landrace and Colombian Gold components, while the sativa-dominant structure ensures the clear-headed, functional effect that defines Harlequin's medical utility.
¶ Cannabinoid Profile
| Cannabinoid | Typical Range |
|---|---|
| THC (Total) | 4-10% |
| CBD | 8-16% |
| CBD:THC Ratio | Approximately 5:2 (varies by phenotype) |
| CBG | 0.3-1.0% |
| CBN | <0.5% (increases with age) |
Harlequin's cannabinoid profile is its defining characteristic. The 5:2 CBD:THC ratio provides therapeutic benefits from both cannabinoids while minimizing THC's intoxicating effects. The CBD content moderates THC's psychoactive impact, producing a clear-headed, functional experience that is well-suited to daytime medical use. Phenotype selection is important -- some Harlequin pheno-hunts express higher CBD ratios than others.
¶ Terpene Profile
| Terpene | Approximate Share | Notes |
|---|---|---|
| Caryophyllene | 25-40% | Primary terpene; spicy, peppery character with anti-inflammatory properties |
| Myrcene | 15-25% | Sweet, herbal notes contributing to the earthy profile |
| Pinene | 10-15% | Pine freshness and mental clarity qualities |
| Humulene | 5-10% | Earthy, hoppy undertones |
| Limonene | 3-7% | Subtle citrus brightness |
The caryophyllene-myrcene-pinene combination produces the earthy-mango-sweet aroma that defines Harlequin.
¶ Effects & Experience
Harlequin is widely reported to produce:
- Clear-headed relief -- Noticeable therapeutic effects without significant intoxication, allowing users to remain functional and productive
- Relaxation without sedation -- A calming physical effect that does not impair mental clarity
- Mild mood lift -- A gentle, uplifting effect from the sativa genetics and modest THC content
- Pain and inflammation reduction -- The high CBD content combined with caryophyllene is frequently reported for physical relief
Onset: Effects begin within minutes when smoked or vaporized; 30-90 minutes when consumed orally.
Duration: 2-4 hours for inhaled consumption; 4-8 hours for oral consumption.
Intensity: Mild to moderate. The effects are subtle and functional rather than overwhelming, making Harlequin suitable for users who need to remain clear-headed during the day.
⚠️ Effects are self-reported and vary by individual, dose, tolerance, and consumption method. Not a prediction of any individual's experience. CBD-rich strains like Harlequin produce significantly less intoxication than high-THC strains.
¶ Aroma & Flavor
- Smell: Earthy and sweet with subtle mango and herbal undertones. The aroma is warm and inviting without being overpowering, reflecting the balanced cannabinoid profile.
- Taste: Earthy and mango-like on the inhale, with sweet and slightly spicy notes on the exhale. The flavor is smooth and approachable, appealing to users who may be sensitive to strong cannabis taste.
¶ Medical Usesdanger
Not Medical Advice -- The following lists commonly reported therapeutic applications. This does not constitute medical advice. Consult a healthcare professional before using cannabis therapeutically.
Commonly reported uses include:
- Chronic pain -- The high CBD content combined with caryophyllene is widely cited for significant pain relief without sedation
- Inflammation -- CBD and caryophyllene are both reported for anti-inflammatory effects
- Anxiety -- The high CBD:THC ratio is frequently recommended for anxiety relief, as CBD moderates THC's anxiety-producing effects
- Seizures and epilepsy -- CBD-rich strains are commonly used as part of seizure management protocols, though patients should consult their physician
- Migraines -- Reported to provide relief while maintaining daytime functionality
- Arthritis -- The anti-inflammatory quality is cited for joint pain and stiffness relief
¶ Adverse Effects
Commonly reported adverse effects:
- Dry mouth
- Dry eyes
- Mild dizziness (less common than with high-THC strains)
- Headache at higher doses
- The mild THC content means adverse effects are generally less severe than with high-THC strains
- Some phenotype selections may express higher THC levels, producing more intoxication than expected
¶ Growing Information
| Attribute | Details |
|---|---|
| Difficulty | Moderate -- requires experience with sativa-dominant growing but generally manageable |
| Flowering Time | 55-65 days (indoor) -- reasonable for a sativa-dominant strain |
| Yield | 350-450 g/m² indoor; 450+ g/plant outdoor |
| Plant Height | Medium -- sativa stretch is moderate; more manageable than pure sativas |
| Preferred Environment | Indoor or outdoor; prefers warm, sunny conditions with good air circulation |
| Resistance | Moderate resistance to mold and pests. The diverse genetic heritage contributes resilience. Responds well to topping and SCROG. |
Harlequin is a moderately challenging strain to grow. Its sativa-dominant characteristics require some height management, but the Nepali indica heritage keeps the plant more compact than pure sativa varieties. The reasonable flowering time (55-65 days) is an advantage. For medical growers, phenotype selection is critical -- growers should test multiple seeds to identify plants expressing the desired high-CBD ratio. Phenotypes can vary significantly in their CBD:THC expression. Outdoor harvest in the Northern Hemisphere typically falls in late September to early October.
¶ Awards & Recognition
- Harlequin has been widely recognized in the medical cannabis community as one of the most reliable and effective high-CBD strains available
- The strain is frequently recommended by medical cannabis practitioners for patients seeking CBD-rich options
- Harlequin appears on dispensary menus across legal markets as a standard high-CBD offering
- While it has not won major recreational Cannabis Cup awards, its significance in the medical cannabis space is well-established
¶ Similar Strains
- Cannatonic -- Comparable high-CBD medical strain
- ACDC -- Similar very high-CBD, low-THC cultivar
- Colombian Gold -- Parent lineage; classic sativa landrace
- Durban Poison -- Comparable energizing sativa with clear-headed effects
Back to Strain Database | Sativa Strains | Strain Template Guide